Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-17

Clinical Trial Update: Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis [NA]

View source ↗

Summary

Clinical trial update reports safety and equivalence of a generic ciclopirox olamine topical suspension to the reference product for treating tinea pedis; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclopirox Olamine topical suspension 0.77% (ciclopirox olamine topical suspension)

Snippet

Sponsor: Padagis LLC | Conditions: Tinea Pedis | NA | Status: COMPLETED | Results posted: 2012-12-17